GLP-1 weight-loss drugs raise nutritional deficiency risk, experts warn
Published 1 d ago1 sourceEvidence: Reported
Peninsula, led by Kline Hill, is reinvesting in Galenicum via a new €150 million continuation vehicle, retaining a 20% stake in the pharma firm known for generic versions of Ozempic and Wegovy. This signals continued private-equity confidence in the GLP-1 generics market, though financial terms and fund structure details remain undisclosed.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago1 sourceEvidence: Reported
Published 3 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago4 sourcesEvidence: Reported
Published 2 d ago5 sourcesEvidence: Reported
Published 19 h ago1 sourceEvidence: Unknown
Published 1 d ago1 sourceEvidence: Reported